Cross-talk between microbiota–gut–brain axis and blood pressure regulation
Clinical Science · 14.05.2025 · 139 (09) · 431-447
DOI: 10.1042/cs20240787 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Science, online erschienen am 08.05.2025. Verfasst von Malindi Welathanthree und 5 weiteren Autor:innen. Beteiligte Einrichtung: Hypertension Research Laboratory, Victorian Heart Institute and Department of Pharmacology, Monash Biomedicine Discovery Institute, Faculty of Medici…. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Blood Pressure, Brain, Hypertension. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 166 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Hypertension, or high blood pressure (BP), is a widespread condition affecting one in three adults globally. Despite the availability of treatment options, 50% of hypertensive patients in countries such as Australia fail to achieve adequate BP control, often due to a lack of response to current therapies. Diet plays a crucial role in BP regulation. A high-fibre diet reduces BP through the gut microbiome and the production of microbial metabolites known as short-chain fatty acids (SCFAs). However, the mechanisms of BP regulation by SCFAs remained still unclear. A novel hypothesis we explore in this review is that these microbial metabolites may regulate BP via the activation of central mechanisms, a phenomenon called the gut–brain axis. While substantial evidence in animal models and humans supports the protective role of SCFAs in hypertension, the precise mechanisms remain unclear. SCFA stimulates the release of neurotransmitters and hormones such as serotonin, cholecystokinin, glucagon-like peptide 1 and peptide YY by enteroendocrine cells, a rare population of cells lining the gastrointestinal tract. These hormones bind to their receptors on the peripheral nervous system nerves, such as the vagus and spinal nerves, conveying information to the brain. The mechanisms by which information is relayed from the gut microbiome to the brain likely involve the immune system and gut-derived neurotransmitters and hormones. A deeper understanding of these pathways and mechanisms will facilitate the development of novel therapeutics for hypertension and other cardiovascular diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hypertension Research Laboratory, Victorian Heart Institute and Department of Pharmacology, Monash Biomedicine Discovery Institute, Faculty of Medicine, Nursing, and Health Sciences, Monash University, Melbourne, Austra…
- Flinders Health and Medical Research Institute, Flinders University, Adelaide, Australia.
- Department of Neuroscience, Monash University, Melbourne, Australia.
- Department of Angiocardioneurology and Translational Medicine, IRCCS Neuromed, Pozzilli, Italy.
- Department of Medical-Surgical Sciences and Biotechnologies, "Sapienza" University of Rome, Latina, Italy.
- Baker Heart and Diabetes Institute, Melbourne, Australia.
ORCID-Profile: Damien J Keating, Vaughan G Macefield, Daniela Carnevale, Francine Z Marques, Rikeish R Muralitharan
Zitieren
APA
Welathanthree, M., Keating, D. J., Macefield, V. G., Carnevale, D., Marques, F. Z., & R Muralitharan, R. (2025). Cross-talk between microbiota–gut–brain axis and blood pressure regulation. Clinical Science, 139(09), 431-447. https://doi.org/10.1042/cs20240787
Vancouver
Welathanthree M, Keating DJ, Macefield VG, Carnevale D, Marques FZ, R Muralitharan R. Cross-talk between microbiota–gut–brain axis and blood pressure regulation. Clinical Science. 2025;139(09):431-447. doi:10.1042/cs20240787
BibTeX
@article{Welathanthree2025,
author = {Welathanthree, Malindi and Keating, Damien J and Macefield, Vaughan G and Carnevale, Daniela and Marques, Francine Z and R Muralitharan, Rikeish},
title = {Cross-talk between microbiota–gut–brain axis and blood pressure regulation},
journal = {Clinical Science},
year = {2025},
volume = {139},
number = {09},
pages = {431--447},
doi = {10.1042/cs20240787}
}
EUVIMED